.jpg)
.png)
All
.color-blue{ color: #23527c; } Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death and disability worldwide. More than 80% of the global burden of ASCVD occurs in low- and middle-income countries.(1) As a means of attenuating this global epidemic, the concept of... more
South Asians are defined as individuals who derive their ethnic origin from the Indian subcontinent. Nearly 3.4 million South Asians currently reside in the United States experiencing a growth of 81% from 2000 to 2010.1 Interestingly, while South Asians account for only 25% of the world’s... more
The Midwest Lipid Association is 510 members strong and represents Indiana, Illinois, Wisconsin, Michigan, Ohio, Kansas, Iowa, Missouri, North Dakota, South Dakota, Minnesota and Nebraska. We are pleased to have David R. Neff, DO, FNLA, serving as our President this year. We have an active and... more
As clinical lipidogists, the major objective of care for most of our patients is to reduce the risk of atherosclerotic cardiovascular disease (ASCVD). All major guideline documents, including the NLA Recommendations for Patient-Centered Management of Dyslipidemia and the 2013 American College of... more
With the rising prevalence of obesity among minority youth in the United States (US),(1,2) there has been a concurrent rise in associated comorbidities such as youth-onset diabetes and hypertension.(3-6) American Indian/Alaska Native (AI/AN) youth are at high risk for obesity that is a predictor of... more
From The New York Times: People who use statin drugs to lower their cholesterol sometimes complain of muscle pain and soreness. But a new study suggests that in some cases these side effects may be a result of combining statins with other medications. The research found that people taking statins... more
Great organizations thrive by looking forward, and the National Lipid Association is no different. In looking forward, we must have a vision of how we will continue to grow our brand and membership, which ultimately helps advance the practice of clinical lipidology. NLA leadership, along with... more
A healthy lifestyle — consisting of no smoking, healthy eating, and physical activity — and adherence to prescribed risk-reducing medication are paramount to primary prevention of atherosclerotic cardiovascular disease (ASCVD). Lifestyle interventions are included as first-line therapy in all major... more
The digital tool entitled "NAFCS Digital PDF scoring tool" is attached for your use. The digital calculator is based on the article published in the Journal of Clinical Lipidology. Hegele et al. wrote the publication utilizing the RAND/UCLA modified Delphi process. The NAFCS manuscript may... more
The 2020-21 NELA Chapter was happy to co-sponsor this edition of the LipidSpin on Telehealth, and the NELA Chapter board would like to personally thank all NELA/ SELA contributors to this issue. The NELA Chapter board and representatives came together for a conference call for the first time in... more